This is read by an automated voice. Please report any issues or inconsistencies here. A study of 24,337 female patients found that COVID-19 is associated with a 2.47 hazard ratio for local breast ...

The likelihood of EGFR-positive lung cancer returning is largely tied to how advanced it is when first diagnosed, with lower chances in early stages and higher odds in later stages. Newer targeted ...

Recurrence risk for stage II to III colon cancer falls below 0.5% 6 years posttreatment, suggesting a potential cure definition. The study analyzed data from 15 phase 3 trials, involving 35,213 ...

A common over-the-counter medication could significantly reduce the risk of colorectal cancer coming back. In a Swedish study, a low dose of aspirin was shown to slash recurrence in half for patients ...

MammaPrint effectively predicts chemotherapy benefit and distant recurrence-free interval in HR+HER2- early breast cancer. High-risk patients benefit significantly from chemotherapy, while low-risk ...

Endoscopic recurrence was observed in one third of patients with Crohn's disease (CD) within 5 years of ileostomy placement, with ileal involvement and prior exposure to biologic therapy being ...

June 6 (Reuters) - (This is an excerpt of the Health Rounds newsletter, where we present latest medical studies on Tuesdays and Thursdays. To receive the full newsletter in your inbox for free sign up ...

Engle and Associates will continue to be led by owners Scott Engle and Jayne Engle Allen Engle and Associates Insurance Brokers was founded in 1980 Relation Insurance Services, which is backed by ...

Patients discontinuing adjuvant immunotherapy early due to toxicity do not have inferior outcomes compared to those completing 12 months of treatment. The study found a 2-year recurrence-free survival ...

Droplet digital polymerase chain reaction (PCR) measurements of circulating tumor DNA (ctDNA) identify patients with stage III melanoma who are at high risk for early recurrence during adjuvant ...

Importance of Defining Recurrence in Hepatocellular Carcinoma: Local or Both Local and Other Intrahepatic Recurrences? The following represents disclosure information provided by the author of this ...

Please provide your email address to receive an email when new articles are posted on . The recurrence-free survival estimate at 5 years was 34% in stage III non-small cell lung cancer. Significant ...